FDA
approval
· 2020-01-10
FDA Approved: VALTOCO — Original Application (Neurelis, Inc)
Summary
The FDA approved VALTOCO, a diazepam nasal spray from Neurelis, Inc., through an original NDA for the acute treatment of seizure clusters in patients with epile…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VALTOCO (DIAZEPAM)